Genetic Privacy

Annual Review of Medicine

Volumn 54, Issue , 2003, Pages 393-407

  Sankar, Pamela ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Duty to warn; Genetic exceptionalism; Genetic testing; Medical confidentiality

Indexed keywords

CONFIDENTIALITY; FAMILIAL DISEASE; GENETIC ANALYSIS; GENETIC COUNSELING; GOVERNMENT; HUMAN; INFORMATION; INFORMED CONSENT; MEDICAL RESEARCH; PRIORITY JOURNAL; PRIVACY; PUBLIC OPINION; REVIEW; UNITED STATES; GENETIC PREDISPOSITION; GENETIC PRIVACY; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; INTERPERSONAL COMMUNICATION; LEGAL ASPECT;

GENETICS AND REPRODUCTION;

CONFIDENTIALITY; DUTY TO WARN; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC SCREENING; HUMANS; TRUTH DISCLOSURE; UNITED STATES;

EID: 0038654365     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.54.101601.152131     Document Type: Review

References (69)

1. Etzioni A. 1999. The Limits of Privacy. New York: Basic Books
2. Tessaro I, Borstelmann N, Regan K, et al. 1997. Genetic testing for susceptibility to breast cancer: findings from women's focus groups. J. Women's Health 6:317-27
3. Geller LN, Alper JS, Billings PR, et al. 1996. Individual, family, and societal dimensions of genetic discrimination: a case study analysis. Sci. Eng. Ethics 2:71-88
4. Gillis J. 2000. Clinton targets misuse of gene data; anti-bias order covers agencies. Washington Post, Feb. 9, p. A19
5. Amos J. 1999. Molecular diagnostics in U.S. clinical laboratories. Presented at Mutations in the Human Genome Conference, Italy, May 13-16; http://www.gene. ucl.ac.uk/hugo/mut_det_abst-bk.html
6. Hall MA, Rich SS. 2000. Laws restricting health insurers' use of genetic information: impact on genetic discrimination. Am. J. Hum. Genet. 66:293-307
7. Annas GJ, Glantz LH, Roche PA. 1995. Drafting the Genetic Privacy Act: science, policy, and practical considerations. J. Law Med. Ethics 23:360-66
8. Gostin LO. 1995. Genetic privacy. J. Law Med. Ethics 23:320-30
9. Orentlicher D. 1997. Genetic privacy in the patient-physician relationship. See Ref. 9a, pp. 77-91
10. Rothstein MA, ed. Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, CT: Yale Univ. Press
11. Andrews LB. 1997. Gen-etiquette: genetic information, family relationships, and adoption. See Ref. 9a, pp. 255-80
12. Pergament E. 1997. A clinical geneticist perspective of the patient-physician relationship. See Ref. 9a, pp. 92-107
13. Murray TH. 1997. Genetic exceptionalism and "future diaries": Is genetic information different from other medical information? See Ref. 9a, pp. 60-73
14. Collins FS, Weiss L, Hudson K. 2001. Heredity and humanity. New Repub., June 25, p. 27
15. Wexler A. 1995. Mapping Fate: a Memoir of Family, Risk, and Genetic Research. New York: Times Books
16. Biesecker BB. 1997. Privacy in genetic counseling. See Ref. 9a, pp. 108-25
17. Scheuer L, Kauff N, Robson M, et al. 2002. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J. Clin. Oncol. 20:1260-68
18. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al. 2000. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015-20
19. Wagner TM, Moslinger R, Langbauer G, et al. 2000. Attitude toward prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br. J. Cancer 82:1249-53
20. National Conference of State Legislatures. State genetic summary table on privacy laws. http://www.ncs1.org/programs/ health/genetics/prt.htm
21. ACLU. 1998. Press release: ACLU urges Senate committee to protect against genetic discrimination. http://www.aclu.org/ news/n052198a.html
22. Steinhardt B. 2000. Statement: ACLU applauds Clinton order barring DNA discrimination in federal workplace. http:// aclu.org/news/2000/n020800a.html
23. Lapham EV, Kozma C, Weiss JO. 1996. Genetic discrimination: perspectives of consumers. Science 274:621-24
24. Council for Responsible Genetics. 2001. Position paper: genetic discrimination. www.gene-watch.org/programs/genetic disc/gd_pp.html
25. Porner P. 2001. Unlocking secrets, closing doors. Chicago Tribune, Jan. 14, p. 1
26. Hustead JL, Cunningham A, Goldman J. 2002. Genetics and Privacy: A Patchwork of Protections. Prepared by Health Privacy Project for Calif. HealthCare Fdn., Washington, DC. http://www.chcf.org/topics/ index.cfm?topic=CL141
27. Rothstein MA. 1997. Genetic secrets: a policy framework. See Ref. 9a, pp. 451-95
28. Billings PR, Kohn MA, Cuevas MD, et al. 1992. Discrimination as a consequence of genetic testing. Am. J. Hum. Genet. 50: 476-82
29. Reilly PR. 1999. Efforts to regulate the collection and use of genetic information. Arch. Pathol. Lab. Med. 123:1066-70
30. Markel H. 1997. Appendix 6. Scientific advances and social risks: historical perspectives of genetic screening programs for sickle cell disease, Tay-Sachs disease, neural tube defects and Down syndrome, 1970-1997. In Final Report of the Task Force on Genetic Testing: Promoting Safe and Effective Genetic Testing in the United States, ed. NA Holtzman, MS Watson. Oak Ridge, TN: Natl. Inst. Health-Dep. Energy Working Group on Ethical, Legal, Social Implic. of Hum. Genome Res.
31. 29a. Pauling L. 1968. Reflections on the new biology. UCLA Law Rev. 15:267
32. Wilcox AJ, Taylor JA, Sharp RR, London SJ. 1999. Genetic determinism and the overprotection of human subjects. Nat. Genet. 21:362
33. Burke W, Pinsky LA, Press NA. 2001. Categorizing genetic tests to identify their ethical, legal, and social implications. Am. J. Med. Genet. 106:233-40
34. Department of Health and Human Services. 2000. Secretary's Advisory Committee on Genetic Testing. Fed. Regist. 65:21094-111
35. Burke W, Kahn M, Garber J, Collins F. 1996. "First do no harm" also applies to cancer susceptibility testing. Cancer J. Sci. Am. 2:250-52
36. Easton DF, Ford D, Bishop DT. 1995. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56:265-71
37. Ford D, Easton DF, Stratton M, et al. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62:676-89
38. Ford D, Easton DF, Peto J. 1995. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 51:1457-62
39. Ford D, Easton DF, Bishop DT, et al. 1994. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692-95
40. Risch HA, McLaughlin JR, Cole DE, et al. 2001. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet. 68:700-10
41. Panguluri RC, Brody LC, Modali R, et al. 1999. BRCA1 mutations in African Americans. Hum. Genet. 105:28-31
42. Park SK, Yoo KY, Lee SJ, et al. 2000. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301-9
43. Tsuang D, Larson EB, Bowen J, et al. 1999. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch. Neurol. 56:1489-95
44. Bluman LG, Rimer BK, Berry DA, et al. 1999. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J. Clin. Oncol. 17:1040-46
45. Evans DG, Burnell LD, Hopwood P, Howell A. 1993. Perception of risk in women with a family history of breast cancer. Br. J. Cancer 67:612-14
46. Hailey B, Carter C, Burnett D. 2000. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care Women Int. 21:701-15
47. Hopwood P, Shenton A, Lalloo F, et al. 2001. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counseling in women with a family history of breast cancer. J. Med. Genet. 38:139-42
48. Giardiello FM, Brensinger JD, Petersen GM, et al. 1997. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N. Engl. J. Med. 336:823-27
49. James C, Geller G, Bernhardt BA, et al. 1998. Are practicing and future physicians prepared to obtain informed consent? The case of genetic testing for susceptibility to breast cancer. Community Genet. 1:203-12
50. Hofman KJ, Tambor ES, Chase GA, et al. 1993. Physicians' knowledge of genetics and genetic tests. Acad. Med. 68:625-32
51. Holtzman NA, Faden RR, Leonard CO, et al. 1991. The effect of education on physicians' knowledge of a laboratory test: the case of maternal serum alpha-fetoprotein screening. J. Clin. Ethics 4:243-47
52. Holtzman NA. 1991. The interpretation of laboratory results: the paradoxical effect of medical training. J. Clin. Ethics 2:241-43
53. Wilcke JT, Seersholm N, Kok-Jensen A, Dirksen A. 1999. Transmitting genetic risk information in families: attitudes about disclosing the identity of relatives. Am. J. Hum. Genet. 65:902-9
54. Goelen G, Rigo A, Bonduelle M, De Greve J. 1999. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing. J. Clin. Oncol. 17:1595-600
55. Applebaum-Shapiro S, Peters J, O'Connell J, et al. 2001. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis. Am. J. Gastroenterol. 96:1610-17
56. Decruyenaere M, Evers-Kiebooms G, Van den Berghe H. 1993. Perceptions of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty? J. Med. Genet. 30:551-61
57. Ayme S, Macquart-Moulin G, Julian-Reynier C, et al. 1993. Diffusion of information about genetic risk within families. Neuromusc. Disord. 3:571-74
58. Leung W-C. 2000. Results of genetic testing: when confidentiality conflicts with a duty to warn relatives. BMJ 321:1464-65
59. Byers T, MacDonald DJ, Severin MJ, Fishbach AA. 1999. Cancer genetic counseling: need for confidentiality versus responsibility to notify. Cancer Prac. 7:93-95
60. American Society of Human Genetics, Social Issues Subcommittee on Familial Disclosure. 1998. ASHG statement: professional disclosure of familial genetic information. Am. J. Hum. Genet. 62:474-83
61. 1995. Pate v. Threlkel, 661 So. 2d 278
62. 1996. Safer v. Estate of Pack, 291 N.J. Super. 619, 677 A.2d 1188 (App. Div.), certification denied, 146 N.J. 568
63. Merz JF. 1999. An update on genetic risks and the duty to warn. PennBioethics 6:3-4
64. Merz JF, Sankar P. 1998. Genetic risks, confidentiality, and duty to warn. PennBioethics 5:1,4
65. Weijer C. 2000. Family duty is more important than rights. BMJ 321:1466
66. 1974. Tarasoff v. Regents of the University of California. 529 P. 2d 553
67. Doukas DJ, Berg JW. 2001. The family covenant and genetic testing. Am. J. Bioethics 1:2-10
68. 2002. Genetic testing results: Who has a "right" to know? Med. Ethics Advisor 18: 49-52
69. Merz J, Cho M, Sankar P. 1998. Familial disclosure in defiance of nonconsent. Am. J. Hum. Genet. 63:898-900